ArticleAnnals of internal medicine2022
In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events.
Chi-Yuan Hsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it